Azilsartan medoxomil/Chlortalidone 40 mg/25 mg Film-coated tablets Irland - Englisch - HPRA (Health Products Regulatory Authority)

azilsartan medoxomil/chlortalidone 40 mg/25 mg film-coated tablets

takeda pharma a/s - azilsartan medoxomil potassium; chlortalidone - film-coated tablet - 40/25 milligram(s) - angiotensin ii antagonists and diuretics; angiotensin ii antagonists and diuretics

Intrarosa Europäische Union - Englisch - EMA (European Medicines Agency)

intrarosa

endoceutics s.a. - prasterone - postmenopause - other sex hormones and modulators of the genital system - intrarosa is indicated for the treatment of vulvar and vaginal atrophy in postmenopausal women having moderate to severe symptoms.,

Zedbac 500 mg powder for concentrate for solution for infusion Irland - Englisch - HPRA (Health Products Regulatory Authority)

zedbac 500 mg powder for concentrate for solution for infusion

aspire pharma limited - azithromycin dihydrate - pdr/conc/soln for infus - 500 milligram(s) - macrolides; azithromycin

Bevespi Aerosphere Europäische Union - Englisch - EMA (European Medicines Agency)

bevespi aerosphere

astrazeneca ab - glycopyrronium, formoterol fumarate dihydrate - pulmonary disease, chronic obstructive - formoterol and glycopyrronium bromide - bevespi aerosphere is indicated as a maintenance bronchodilator treatment to relieve symptoms in adult patients with chronic obstructive pulmonary disease (copd).

Zedbac 500 mg powder for concentrate for solution for infusion Irland - Englisch - HPRA (Health Products Regulatory Authority)

zedbac 500 mg powder for concentrate for solution for infusion

european regulatory affairs t/a ivowen - azithromycin dihydrate - powder for concentrate for solution for infusion - 500 milligram(s) - macrolides; azithromycin

Riltrava Aerosphere Europäische Union - Englisch - EMA (European Medicines Agency)

riltrava aerosphere

astrazeneca ab - budesonide, formoterol fumarate dihydrate, glycopyrronium bromide - pulmonary disease, chronic obstructive - drugs for obstructive airway diseases, - riltrava aerosphere is indicated as a maintenance treatment in adult patients with moderate to severe chronic obstructive pulmonary disease (copd) who are not adequately treated by a combination of an inhaled corticosteroid and a long-acting beta2 agonist or combination of a long-acting beta2 agonist and a long-acting muscarinic antagonist (for effects on symptoms control and prevention of exacerbations see section 5.1).

Zedbac 500 mg powder for concentrate for solution for infusion Irland - Englisch - HPRA (Health Products Regulatory Authority)

zedbac 500 mg powder for concentrate for solution for infusion

morningside healthcare (malta) limited - azithromycin dihydrate - powder for concentrate for solution for infusion - macrolides; azithromycin